AGOURON Trademark

Trademark Overview

On Friday, November 17, 1995, a trademark application was filed for AGOURON with the United States Patent and Trademark Office. The USPTO has given the AGOURON trademark a serial number of 75025475. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, June 8, 2017. This trademark is owned by Agouron Pharmaceuticals, Inc.. The AGOURON trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, pharmaceuticals for use in the treatment of [ cancer ], viral disease and [ inflammatory disease ]
agouron

General Information

Serial Number75025475
Word MarkAGOURON
Filing DateFriday, November 17, 1995
Status800 - REGISTERED AND RENEWED
Status DateThursday, June 8, 2017
Registration Number2068730
Registration DateTuesday, June 10, 1997
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 18, 1997

Trademark Statements

Goods and Servicespharmaceuticals, namely, pharmaceuticals for use in the treatment of [ cancer ], viral disease and [ inflammatory disease ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 2, 1996
Primary Code005
First Use Anywhere DateMonday, October 23, 1995
First Use In Commerce DateMonday, October 23, 1995

Trademark Owner History

Party NameAGOURUN PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSAN DIEGO, CA 92121
Party NameAgouron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameAgouron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037
Party NameAgouron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Monday, May 13, 1996ASSIGNED TO EXAMINER
Tuesday, May 14, 1996ASSIGNED TO EXAMINER
Thursday, May 30, 1996NON-FINAL ACTION MAILED
Wednesday, November 6, 1996CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 1997APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 14, 1997NOTICE OF PUBLICATION
Tuesday, March 18, 1997PUBLISHED FOR OPPOSITION
Tuesday, June 10, 1997REGISTERED-PRINCIPAL REGISTER
Tuesday, June 10, 2003TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 11, 2003REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, August 14, 2003REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 7, 2006TEAS SECTION 8 & 9 RECEIVED
Monday, August 7, 2006REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Thursday, October 26, 2006REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, October 26, 2006REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, December 5, 2006CASE FILE IN TICRS
Wednesday, June 6, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 27, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 10, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, June 10, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 6, 2017TEAS SECTION 8 & 9 RECEIVED
Thursday, June 8, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, June 8, 2017REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, June 8, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, January 30, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 30, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 30, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 30, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

agouron pharmaceuticals disease inflammatory viral cancer namely treatment